Oligonucleotide-based gene therapy for cardiovascular disease (Q40836396)

24 September 2017

1 reference

title

Oligonucleotide-based gene therapy for cardiovascular disease (English)

1 reference

24 September 2017

0 references

2

1 reference

24 September 2017

R Morishita

1

1 reference

24 September 2017

Y Taniyama

3

1 reference

24 September 2017

H Matsushita

4

1 reference

24 September 2017

K Yamamoto

5

1 reference

24 September 2017

N Tomita

6

1 reference

24 September 2017

A Moriguchi

7

1 reference

24 September 2017

K Matsumoto

8

1 reference

24 September 2017

J Higaki

9

1 reference

24 September 2017

T Ogihara

10

1 reference

24 September 2017

publication date

1 August 1998

1 reference

Clinical Chemistry and Laboratory Medicine

24 September 2017

published in

1 reference

24 September 2017

volume

36

1 reference

24 September 2017

issue

8

1 reference

24 September 2017

page(s)

529-534

1 reference

The emerging concept of vascular remodeling

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

Retinoblastoma protein switches the E2F site from positive to negative element

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

Association of cdk2 Kinase with the Transcription Factor E2F During S Phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

Genetic engineering of vein grafts resistant to atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

Regulation of gene expression with double-stranded phosphorothioate oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

Activation and attenuation of transcription factor NF-kB in mouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3':5'-cyclic monophosphate. Evidence for involvement of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

ICAM-1 expression in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

Mesangial cell accessory functions: mediation by intercellular adhesion molecule-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

Functional analysis of the human vascular cell adhesion molecule 1 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

The stability of different forms of double-stranded decoy DNA in serum and nuclear extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

Molecular Delivery System for Antisense Oligonucleotides: Enhanced Effectiveness of Antisense Oligonucleotides by HVJ-liposome Mediated Transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

Antisense approaches to the gene therapy of cancer--'Recnac'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

Multiple mechanisms may contribute to the cellular anti-adhesive effects of phosphorothioate oligodeoxynucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

Review of in vivo pharmacokinetics and toxicology of phosphorothioate oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a four-week study in cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

Human gene therapy comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1998.090

21 January 2018

Identifiers

DOI

10.1515/CCLM.1998.090

1 reference

24 September 2017

1 reference